From: Epidemiology of Clostridium difficile infection in Asia
(Reference) | Number of isolates | [Resistance rate] (%), MIC50 (mg/L), MIC90 (mg/L) | |||||||
---|---|---|---|---|---|---|---|---|---|
Erythromycin | Clindamycin | Tetracycline | Moxifloxacin | Ciprofloxacin | Piperacillin/ tazobactam | Metronidazole | Vancomycin | ||
China | Â | Â | Â | Â | Â | Â | Â | Â | Â |
[37] | 75 | [76], 128, 128 | [66.7], 128, 128 | [41.3], 4, 64 | [45.3], 4, 128 | [100], 64, 128 | [0], <16/4, 16/4 | [0], 0.25, 0.25 | [0], 1, 2 |
[39] | 110 | [85.3], 128, 128 | [88.1], 128, 128 | [62.7], 16, 32 | [61.8], 16, 128 | [100], 64, 128 | [0], 8/4, 16/4 | [0]a, 0.125, 0.25 | [0], 0.5, 1 |
Hong Kong | Â | Â | Â | Â | Â | Â | Â | Â | Â |
[40] | 35 | Â | Â | Â | Â | [100] | Â | 0.5, 0.75 | 0.75, 1.5 |
Japan | Â | Â | Â | Â | Â | Â | Â | Â | Â |
[77] | 73 | [87.7], >256, >256 | [87.7], >256, >256 | Â | Â | [100], >32, >32 | Â | [0], 0.19, 0.25 | [0], 2, 4 |
[16] | 72 | Â | Â | Â | [12]b | [100] | Â | [0] | [0] |
Korea | Â | Â | Â | Â | Â | Â | Â | Â | Â |
[31] | 120 | Â | [50], 128, >128 | Â | [42], 2, 16 | Â | [0], 8, 16 | [0], 1,4 | [0], 0.5, 1 |
[19] | 111 | Â | [82] | Â | [83] | Â | Â | Â | Â |
[33] | 131 | Â | [67.9] | Â | [82] | Â | Â | [0] | [0] |
[78] | 123 | Â | [75] | Â | [85] | Â | Â | Â | Â |
Singapore | Â | Â | Â | Â | Â | Â | Â | Â | Â |
[60] | 68 | Â | [63], 8, >512 | Â | Â | Â | Â | [0], 0.5, 1 | [0], 1, 1 |
Taiwan | Â | Â | Â | Â | Â | Â | Â | Â | Â |
[79] | 60 | Â | [73.3], 16, 64 | [41.7], 8, >16 | [30] | [100] | Â | Â | Â |
[47] | 113 | Â | [46], 4, >256 | Â | [16] | Â | Â | [0] | Â |